Stockscreener 앱 받기
7.18
0.14%
0.010
Ataibeckley Inc 주식(ATAI)의 최신 뉴스
ATAI Stock Soars On Eli Lilly’s $2.8B Buyout – Why Are CMPS Shares Rising Too? - Stocktwits
AtaiBeckley Inc. Revenue Breakdown – MUN:B72 - TradingView
AtaiBeckley Inc. Revenue Breakdown – FWB:B72 - TradingView
ATAI Stock Eyes Rocketing Back To 4-Year Highs: VC Sees Up to 105% Takeover Premium From Eli Lilly - Stocktwits
AtaiBeckley Inc. Revenue Breakdown – LS:A41WEP - TradingView
Is AtaiBeckley (ATAI) A Bargain On Eli Lilly’s Takeover Deal? - simplywall.st
AtaiBeckley Inc. (ATAI) stock price, news, quote and history - Yahoo Finance UK
Why Is ATAI Stock Soaring 59% After-Hours? - Stocktwits
Form DEF 14A ATAI Beckley Inc For: 23 July By Investing.com - Investing.com Canada
How Much Upside is Left in AtaiBeckley Inc (ATAI)? Wall Street Analysts Think 33.33% - Yahoo Finance
Key facts: Zepbound tops Wegovy; Novo sues; Lilly buys AtaiBeckley - TradingView
Lilly-AtaiBeckley Deal A Stamp Of Approval For Psychedelics - Law360
Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders? - TradingView
H.C. Wainwright downgrades AtaiBeckley stock rating on Lilly deal By Investing.com - Investing.com India
H.C. Wainwright downgrades AtaiBeckley stock rating on Lilly deal - Investing.com UK
Tracking Cathie Wood: Backing Prime Medicine and SpaceX, Sells Off AtaiBeckley, Shopify - Moomoo
Eli Lilly Acquires AtaiBeckley to Expand Mental Health Treatment Pipeline in $3.8 Billion Deal - Global Legal Chronicle
AtaiBeckley (NASDAQ:ATAI) shares reflect 18% implied value for acquisition milestone entitlements - TechStock²
ATAIBECKLEY INC : BERENBERG CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $7.45 FROM $14 - Bitget
AtaiBeckley (ATAI) H.C. Wainwright 26th Annual Global Investment Conference 2024 summary - Quartr
ATAIBECKLEY INC : TD COWEN CUTS TO HOLD FROM BUY - Bitget
H.C. Wainwright Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $7.5 - Moomoo
J&J, AbbVie said to have also looked at AtaiBeckley before Lilly’s $2.8B deal - Endpoints News
ATAI Stock Downgraded Across Wall Street – Why Analysts Believe Buyout By Eli Lilly Capped Near-Term Upside - TradingView
Berenberg Downgrades AtaiBeckley to Hold From Buy, Adjusts Price Target to $7.45 From $14 - Moomoo
TD Cowen Downgrades AtaiBeckley to Hold From Buy - marketscreener.com
Lilly Joins Psychedelic Drug Race With AtaiBeckley Buyout – Merger Arbitrage Mondays (NASDAQ:ATAI) - Seeking Alpha
Weekly Recap: Eli Lilly acquisition of AtaiBeckley and BPL-003 Phase 3 - TradingView
ATAI Stock Slips After Blockbuster Week: Cathie Wood Calls $3.8B Lilly Deal ‘Well-Deserved’ Return For Shareholders - TradingView
Why Did ATAI, PANW, TRV Stocks Surge To 52-Week Highs Last Week? - Yahoo Finance
AtaiBeckley (NASDAQ:ATAI) shares trade with Merger CVR valued near 19% of face - TechStock²
Why Did AAPL, ATAI, UNH Stocks Jump To 52-Week Highs Today? - Stocktwits
Eli Lilly (LLY) to Acquire AtaiBeckley for $2.8B - GuruFocus
Berenberg Bank Sticks to Their Buy Rating for Atai Beckley N.V. (ATAI) - The Globe and Mail
Maxim Group Maintains AtaiBeckley(ATAI.US) With Hold Rating - Moomoo
Eli Lilly psikedelik ilaç üreticisi AtaiBeckley’yi 2,8 milyar dolara satın alıyor; zihinsel hastalık tedavilerinde yeni seçeneklerin devreye girmesi bu satın almanın gündeme gelmesinde önemli bir etken. Bu satın almayla Lilly, AtaiBeckley’nin deneysel DMT bazlı ila - instagram.com
TD Cowen Downgrades AtaiBeckley(ATAI.US) to Hold Rating - Moomoo
Form 13D/A AtaiBeckley Inc. For: 17 July By Investing.com - Investing.com Canada
AtaiBeckley Inc. (NASDAQ: ATAI) investor commits 15.4% stake to Lilly deal - Stock Titan
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc.ATAI - Business Wire
Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion - Benzinga
A Quick Look at Today's Ratings for AtaiBeckley(ATAI.US), With a Forecast Between $7.5 to $8 - Moomoo
Eli Lilly Expands with $2.8B Psychedelic Acquisition - Investing News Network
Eli Lilly to Boost Neuroscience Pipeline With AtaiBeckley Buyout - TradingView
Eli Lilly Drops $3.8 Billion on AtaiBeckley, Sending Psychedelic Stocks Soaring - finance.biggo.com
This ONEOK Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday - Benzinga
Eli Lilly agrees to $3.8B psychedelic buy - Axios
Biotech Growth says Eli Lilly's $2.8bn swoop on AtaiBeckley underlines the value of smaller drug developers - QuotedData
Lilly to buy AtaiBeckley in $3.8B psychedelic push - MSN
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time - TradingView
AtaiBeckley acquisition highlights growing Big Pharma interest in psychedelics, says Jefferies - Proactive financial news
AtaiBeckley (NASDAQ:ATAI) shares reflect merger rights valued at 14% of par - TechStock²
Canaccord Genuity Downgrades AtaiBeckley to Hold From Buy, Adjusts PT to $8 From $17 - Moomoo
Eli Lilly (LLY) Is Buying AtaiBeckley To Enter Psychedelic Mental Health Treatments - simplywall.st
Jefferies Downgrades AtaiBeckley to Hold From Buy, Adjusts PT to $7.50 From $10 - marketscreener.com
0.46%
0.84%
자본화:
|
볼륨(24시간):